Here are five quick facts:
1. Needham & Company lowered their target price on K2M Group Holdings stock from $30 to $25.
2. On Nov. 4, Needham & Company analysts gave the shares a “buy” rating.
3. CFO Gregory S. Cole sold 41,574 company shares in a transaction totaling $819,007.80.
4. On Jan. 11, K2M Group Holdings shares fell 7.76 percent.
5. The market cap is $600.69 million.
More articles on devices:
Medtech revenue up 168%: 5 insights
University of Delaware receives magnet for enhanced imaging of brain: 3 things to know
Flowers Hospital in Alabama installs Stealth system: 4 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
